Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis.
James
C
C
Delhommeau
F
F
Marzac
C
C
Teyssandier
I
I
Couédic
J-P Le
JP
Giraudier
S
S
Roy
L
L
Saulnier
P
P
Lacroix
L
L
Maury
S
S
Tulliez
M
M
Vainchenker
W
W
Ugo
V
V
Casadevall
N
N
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001322:Autoanalysis; D045744:Cell Line, Tumor; D005260:Female; D006801:Humans; D053614:Janus Kinase 2; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000175:diagnosis / Q000235:genetics; D011086:Polycythemia / Q000175:diagnosis* / Q000235:genetics*; D011087:Polycythemia Vera / Q000145:classification / Q000175:diagnosis* / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D011237:Predictive Value of Tests; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D012680:Sensitivity and Specificity; D013696:Temperature
D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2